|
⚲
|
| Keyboard |
| Swain Judith L
✚
|
|
|---|---|
| CIK # | 0001413573 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001413573] | |
| 4 | [0001413573] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Swain Judith L | |
| Lexicon Pharmaceuticals Inc | |
| Prometheus Biosciences Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Lexicon Pharmaceuticals Inc LXRX
Stock Option (Right to Buy) · derivative
|
2025-06-03 | Grant | 103,806 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Restricted Stock Units · derivative
|
2025-06-03 | Grant | 89,312 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2025-05-13 | Option exercise | 36,810 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Restricted Stock Units · derivative
|
2025-05-13 | Option exercise | 36,810 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Stock Option (Right to Buy) · derivative
|
2024-05-13 | Grant | 44,906 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Restricted Stock Units · derivative
|
2024-05-13 | Grant | 36,810 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Restricted Stock Units · derivative
|
2024-04-28 | Option exercise | 8,032 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2024-04-28 | Option exercise | 8,032 | $0.00 | |
|
Prometheus Biosciences Inc RXDX
Common Stock
|
2023-06-16 | Disposed to issuer | 2,071 | ||
|
Prometheus Biosciences Inc RXDX
Stock Option (right to buy) · derivative
|
2023-06-16 | Disposed to issuer | 30,000 | ||
|
Prometheus Biosciences Inc RXDX
Stock Option (right to buy) · derivative
|
2023-06-16 | Disposed to issuer | 20,500 | ||
|
Lexicon Pharmaceuticals Inc LXRX
Restricted Stock Units · derivative
|
2023-05-21 | Option exercise | 9,302 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2023-05-21 | Option exercise | 9,302 | $0.00 | |
|
Prometheus Biosciences Inc RXDX
Common Stock
|
2023-05-19 | Grant | 2,071 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Restricted Stock Units · derivative
|
2023-04-28 | Grant | 8,032 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Stock Option (Right to Buy) · derivative
|
2023-04-28 | Grant | 12,658 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Stock Option (Right to Buy) · derivative
|
2022-05-21 | Grant | 14,402 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Restricted Stock Units · derivative
|
2022-05-21 | Grant | 9,302 | $0.00 | |
|
Prometheus Biosciences Inc RXDX
Stock Option (Right to Buy) · derivative
|
2022-05-19 | Grant | 20,500 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2022-04-30 | Option exercise | 4,024 | $0.00 | |
| showing 20 of 45 most recent transactions | |||||